Cytokine Modulators
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)contractFind a Tender ↗Ref ocds-h6vhtk-02923c32014L0024active
Estimated value
—
goods
Awarded value
—
Suppliers
19
5 SME
Lots
8
8 awarded
Published
11 Feb 2021
Description
Supply of Cytokine Modulators to NHS Scotland which is used to treat licensed indications. Etanercept Infliximab Adalimumab Methotrexate The Goods have been split into eight (8) categories, each of which are identified as a “Lot”. Full details of each Lot are contained in section II.2 of this notice.
Scope
- Reference
- NP47920
- Commercial tool
- Standalone contract
- Main category
- goods
- CPV classifications
- 33600000
- Contract locations
- Scotland
Award criteria
Criteria the buyer will use to evaluate bids.
| Name | Description | Type | Weighting |
|---|---|---|---|
| Supply Chain | 5 | quality | — |
| — | 95 | price | — |
Submission & procedure
- Procedure
- Open procedure
Award details· 8 awards
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
—
Award date
—
Contract start
—
Contract end
—
Awarded to
Lots · 8 total
Divisions of the contract. Each lot can be awarded separately.
| Lot | Title | Est. value | Status |
|---|---|---|---|
| 3 | Infliximab Subcutaneous | — | cancelled |
| 4 | Adalimumab | — | cancelled |
| 5 | Methotrexate (50 mg per 1 ml concentration ) pre-filled self injection device | — | cancelled |
| 6 | Methotrexate (50 mg per 1 ml concentration ) pre-filled syringes | — | cancelled |
| 7 | Methotrexate (25 mg per 1 ml concentration ) pre-filled self injection device | — | cancelled |